欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
PT/H/1393/001
药品名称
Moxifloxacina Hikma
活性成分
moxifloxacin 400.0 mg/250 ml
剂型
Solution for infusion
上市许可持有人
Hikma Farmacêutica (Portugal), S.A.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Austria (AT)
Moxifloxacin Hikma 400 mg/250 ml Infusionslösung
许可日期
2017/03/08
最近更新日期
2024/01/02
药物ATC编码
J01MA14 moxifloxacin
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final SPC
|
common-spc-moxifloxacin-dcp-var002 (tracked)
Date of last change:2020/08/03
Final PL
|
common-pl-moxifloxacin-dcp-var002 (tracked)
Date of last change:2020/08/03
Final Product Information
|
common-outer-moxifloxacin-dcp-v0-apr16
Date of last change:2017/08/17
Final Product Information
|
common-pl-moxifloxacin-dcp-v0-feb17
Date of last change:2017/08/17
Final Product Information
|
common-impack-moxifloxacin-dcp-v0-apr16
Date of last change:2017/08/17
Final Product Information
|
common-spc-moxifloxacin-dcp-v0-mar17
Date of last change:2017/08/17
PAR
|
604622_20170307_PAR_GBB
Date of last change:2017/08/17
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase